Build Smarter, Faster Science with a Platform That Works Like You Do

Connect experiments, data, and teams in one integrated environment. Dotmatics brings structure to scientific complexity, supporting decision-making, reproducibility, and real-world progress in modern R&D.

Homepage product hero

Tailored Solutions for Biology, Chemistry, and Materials R&D

Multi-modal Biologics R&D

Enable teams to easily and collaboratively capture and track high volumes of data in order to make the best-informed decisions across biologic drug discovery modalities.

Geneious Icon

Geneious

Molecular biology & sequence analysis tools

SnapGene Icon

SnapGene

Core molecular biology procedures

Prism Icon

Prism

Statistical analysis and graphing

Small Molecule Drug Discovery R&D

Simplify discovery and development, from hit and lead identification to developing a new drug, so project teams can make better informed decisions based on your data.

Prism Icon

Prism

Statistical analysis and graphing

Vortex Icon

Vortex

Chemicals & Materials R&D

Designed and built for use directly by researchers, supporting decision making that brings premium products to market sooner, at a lower cost.

Platform to deliver more predictable results image

The Dotmatics Advantage

The Platform to Deliver More Predictable Results, Faster

  • Accelerate research with streamlined data flow
  • Elevate insights with unparalleled breadth and depth
  • Maximize data value with powerful integrations.  
  • Improve productivity with out-of-the-box workflows.

The World’s Top Research Teams Work with Dotmatics.

Customer Impact

Driving Drug Discovery with Data Intelligence & Collaboration

“From our perspective as a CRO, Dotmatics provides outstanding flexibility, scalability, and ease of use for Sygnature scientists, making it the ideal solution for our integrated drug discovery projects. It has greatly improved the efficiency of the design-make-test-analyze cycle, saved valuable time and enhanced productivity. This allows our scientists to focus on what truly matters — discovering new medicines.”

Ting Qin, Senior Principal Scientist

Sygnature Discovery